1 / 30

Pharmacology of Interferon

Pharmacology of Interferon. Interferon. Natural Interferons. Man Made Interferons (Recombinant). Interferon Basics. Interferons play an important role in the first line of defense against viral infections Interferons are part of the non-specific immune system

edna
Download Presentation

Pharmacology of Interferon

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PharmacologyofInterferon

  2. Interferon Natural Interferons Man Made Interferons (Recombinant)

  3. Interferon Basics • Interferons play an important role in the first line of defense against viral infections • Interferons are part of the non-specific immune system • Interferons are made by cells in response to an appropriate stimulus

  4. Types on Interferon • alpha (leukocyte interferon) • produced by virus infected leukocytes • beta (fibroblast interferon) • produced by virus infected fibroblasts or epithelial cells • gamma (immune interferon) • produced by certain activated T cells & NK cells

  5. How Does It Prevent Viral Replication? virus cells (Other stimuli: exogenous ds RNA, LPS, bacterial components)

  6. How Does It Prevent Viral Replication? virus interferon

  7. How Does it Prevent Viral Replication? No replication virus Inhibitory proteins

  8. Interferon Response to Acute Viral Infection

  9. Effects of Interferon Treatment

  10. Mechanisms of Action • IFN alpha and beta • induction of inhibitory protein synthesis • IFN gamma • inc class II MHC molecules of APC • Inc ability of macrophages to resist viral infx and kill other cells if infected • All IFN • inc class I MHC molecules • inc activity of NK cells

  11. Viral Defense Against Interferon • block interferon binding to cells • inhibit action of interferon-induced protein kinase • inhibit NK function • interfere with cell surface expression MHC • block complement activation • prevent apoptosis in host cell

  12. Indications for Interferon • alpha • Hepatitis B & C, Hairy cell leukemia, Chronic myeloid leukemia, multiple myeloma, low grade lymphomas, Kaposi’s Sarcoma, Melanoma • beta • Multiple Sclerosis, (Ulcerative colitis)

  13. Indications for Interferon • gamma • Chronic granulomatous disease, Chronic Myeloid Leukemia, Renal cell Carcinoma

  14. Incomplete List of Interferons • Actimmune • Alferon • Avonex • Betaserone • Infergen • Intron • Wellferon, etc

  15. HCV Epidemiology • HCV is leading cause of liver disease • 4 million Americans have been exposed • approx 3 million are infected • HCV infection leads to decompensated cirrhosis and hepatocellular carcinoma • HCV-related cirrhosis is the most common reason for OLT in the US NIH Consensus Development Conference Statement 2002

  16. Distribution of HCV

  17. Management of Hepatitis C • Consensus Statement in 2002 • treatment eligible patients • IVD users, consume alcohol, comorbidities (depression, HIV coinfections) • pegylated interferon with ribiviran better than peginterferon monotherapy or standard interferon-ribivarin

  18. HCV Infection

  19. Interferon in Hepatitis C • Monotherapy • standard interferon 3 Million units inj tiw (Low Sustained virologic response) • Combination therapy • standard interferon with ribivarin • pegylated interferon with ribivarin

  20. Interferon in HCV • Limitations • monotherapy not very effective • cumbersome dosing (TIW) • multiple side effects

  21. Interferon Side Effects (Hepatitis C Data) • Flu-like symptoms • Headache • Nausea, vomiting, diarrhea • Depression, irritability, anxiety • Injection site reactions, partial alopecia • Hematologic abnormalities • Autoimmune disorders

  22. Management of Side Effects • Depression (77% Manns et al, Lancet 2001) • NIH consensus - “monitor patients for depression and prescribe antidepressants when necessary” • Hematologic abnormalities • neutropenia and thrombocytopenia • treatment options include decreasing dose or giving hematopoietic growth factors

  23. Pegylated Interferon • HCV is an ideal setting for peginterferon • polyethylene glycol (PEG):interferon • Pegylation was developed to overcome disadvantages of standard interferon • shields IFN from enzymatic degradation thus lowers systemic clearance • allows less frequent dosing • achieve higher/sustained serum [interferon]

  24. Fried et al: Peginterferon Alfa-2a Plus Ribavirin 56% 44% 29% P=<0.001

  25. Differences in PEG • peginterferon alfa-2b • linear molecule • weight 12 kDa • peginterferon alfa-2a • larger, branched molecule • weight 40 kDa

  26. Peginterferon

  27. Pharmacologic Parameters of Peginterferons

  28. Weight-Based Dosing and Peginterferon Therapy • Once weekly dosing • alfa 2b • weight based dosing (1-1.5 mcg/kg/week) • high volume of distribution • kidney, heart, liver and throughout the bloodstream • alfa 2a • fixed dose at 180 mcg/week • low volume of distribution

  29. Conclusions • Interferons are important in the nonspecific immune response • Interferons are effective in the treatment of patients with chronic hepatitis • Pegylated interferons are superior therapies for patients with HCV • Side effects should be monitored closely

More Related